Table 2.

Comparison of the level of glucose and lipid profiles in Aloe vera - and placebo-treated groups

Variables	Time	PL	Within group	AL300	Within group	AL500	Within group	Between group
		N = 23	P-value	N = 23	P-value	N = 24	P-value	P-value
FBS (mg/dl)	Before intervention	110 ± 3.91	-	112 ± 2.5	-	111 ± 4.1	-	0.69
	Fourth week	109 ± 4.14	0.92	109 ± 2.77*	0.006	108 ± 3.9*	0.001	0.009*
	Eighth week	110 ± 4.22	0.19	108 ± 2.78*	0.001	104 ± 4.2*	<0.001	0.001*
Hb A1C (%)	Before intervention	6.01 ± 0.16	-	6 ± 0.24	-	6 ± 0.23	-	0.37
	Eighth week	6.03 ± 0.14	0.059	5.8 ± 0.21*	0.042	5.6 ± 0.33*	0.011	0.04*
LDL-C (mg/dl)	Before intervention	149.7 ± 1.08	-	148.7 ± 0.94	-	151.6 ± 1.04	-	0.12
	Fourth week	150 ± 1.13	0.29	147.5 ± 0.52	0.24	146 ± 1.32	0.12	0.06
	Eighth week	150.7 ± 1.2	0.34	145.4 ± 1.31	0.37	137.5 ± 1.44*	0.01	0.01*
CHOL-C (mg/dl)	Before intervention	242 ± 3.13	-	241 ± 6.9	-	243 ± 10.4	-	0.21
	Fourth week	242 ± 3.24	0.73	238 ± 6.4	0.25	228 ± 11.6	0.053	0.04*
	Eighth week	243 ± 3.52	0.92	235 ± 8.1	0.13	218 ± 11.81*	<0.001	0.006*
TG (mg/dl)	Before intervention	173 ± 1.41	-	176.4 ± 1.5	-	179 ± 2.26	-	0.78
	Fourth week	173.3 ± 1.41	0.54	178.2 ± 2	0.19	174.8 ± 2.35	0.045	0.1
	Eighth week	173.6 ± 1.41	0.82	175.4 ± 2.08	0.072	168.6 ± 2.87*	0.005	0.03*
HDL-C (mg/dl)	Before intervention	31.95 ± 1.29	-	30.43 ± 1.50	-	31.1 ± 2.05	-	0.26
	Fourth week	31.82 ± 1.15	0.18	33.6 ± 3.99	0.25	33.6 ± 3.99	0.11	0.01*
	Eighth week	31.69 ± 1.45	0.09	35.3 ± 3.73*	0.08	35.3 ± 3.73*	0.004	0.007*

The within groups p values are for the comparison between the fourth week or the eighth week with baseline in the same group. * p <0.05: compared with the corresponding time in the placebo group.

All data are expressed as Mean ± SD. PL = placebo group. AL300 = the group that received 300 mg capsule of Aloe vera. AL500 = the group that received 500 mg capsule of Aloe vera.